Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now indicates the study is not recruiting participants, reflecting a recruitment status change. It also adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision tag to v3.6.0.SummaryDifference0.6%

- Check20 days agoChange DetectedThe page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating an updated release tag for the page.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3. This indicates a minor update to the page's versioning metadata rather than content changes.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s displayed software/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a backend/site revision without changing the study record content.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 (v3.4.3 removed).SummaryDifference0.1%

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.